Résultats de la recherche - Hemalatha G. Rangarajan
- Résultat(s) 1 - 11 résultats de 11
-
1
-
2
Safety Profile of Good Manufacturing Practice Manufactured Interferon γ-Primed Mesenchymal Stem/Stromal Cells for Clinical Trials par Adam J. Guess, Beth Daneault, Rongzhang Wang, Hillary Bradbury, Krista M. D. La Perle, James Fitch, Sheri L. Hedrick, Elizabeth Hamelberg, Caroline Astbury, Peter White, Kathleen Overolt, Hemalatha G. Rangarajan, Rolla Abu‐Arja, Steven M. Devine, Satoru Otsuru, Massimo Dominici, Lynn O’Donnell, Edwin M. Horwitz
Publié 2017Artigo -
3
Outcomes of Non-Myeloablative HLA-Haploidentical Bone Marrow Transplant with Thiotepa and Post-Transplant Cyclophosphamide in Children and Adults with Sickle Cell Disease, a Phase... par Adetola A. Kassim, Karina Wilkerson, Josu de la Fuente, Adriana Seber, Roseane Vasconcelos Gouveia, Carmem Bonfim, Belinda Pinto Simões, Erfan Nur, Biljana Horn, Michael J. Eckrich, Rabi Hanna, Nathalie Dhédin, Fahed Almhareb, Mahmoud Aljurf, Hemalatha G. Rangarajan, Katie S. Gatwood, J. Connelly, Mohsen Alzahrani, Ali Alahmari, Mark Rodeghier, Michael R. DeBaun
Publié 2022Artigo -
4
Early Donor T-Cell Engraftment Is Critical for Immune Tolerance in Reduced Intensity Haploidentical Bone Marrow Transplant with Post-Transplant Cyclophosphamide for Sickle Cell Dis... par Jim A. Connelly, Eden Biltibo, Karina Wilkerson, Adriana Seber, Roseane Vasconcelos Gouveia, Carmem Bonfim, Belinda Pinto Simões, Erfan Nur, Biljana Horn, Michael J. Eckrich, Rabi Hanna, Nathalie Dhédin, Fahed Almhareb, Mahmoud Aljurf, Hemalatha G. Rangarajan, Katie S. Gatwood, Lindsay Orton, Carrie L. Kitko, Mohsen Alzahrani, Ali Alahmari, Josu de la Fuente, Adetola A. Kassim
Publié 2022Artigo -
5
CD33 CAR T-Cells (CD33CART) for Children and Young Adults with Relapsed/Refractory AML: Dose-Escalation Results from a Phase I/II Multicenter Trial par Nirali N. Shah, Sarah K. Tasian, M. Eric Kohler, Emily M. Hsieh, Susanne H.C. Baumeister, Corinne Summers, Haneen Shalabi, Jessica A. Pollard, Bonnie Yates, Ruta Brazauskas, Eric Ndifon, Constance M. Yuan, Hao‐Wei Wang, Hati Kobusingye, Kayla Christianson, Allison A Weiss, Erin Leckrone, Bronwen E. Shaw, Jeffery J. Auletta, Hemalatha G. Rangarajan, John Roach, Julie Blake, Dennis F. Michiel, Brian Bowser, Sheryl Ruppel, George Mitra, Anthony Welch, Jason L. Yovandich, Rachelle Salomon, Leslie S. Kean, Katherine Tarlock, Michael A. Pulsipher, Michael R. Verneris, Larisa Broglie, Terry J. Fry, Steven M. Devine, Richard Aplenc
Publié 2023Artigo -
6
Outcomes of Non-Myeloablative HLA-Haploidentical Bone Marrow Transplant with Thiotepa and Post-Transplant Cyclophosphamide in Children and Adults with Severe Sickle Cell Disease, a... par Adetola A. Kassim, Josu de la Fuente, Ali Alahmari, Michael J. Eckrich, Rabi Hanna, Nathalie Dhédin, Biljana Horn, Vandy Black, Roseane Vasconcelos Gouveia, Adriana Seber, Belinda Pinto Simões, Thalita Cristina de Mello Costa, Renato Cunha, Carmem Bonfim, Roberto Luiz da Silva, Nelson Hamerschlak, Juliana Folloni Fernandes, Michael Kent, Satya Prakash Yadav, Erfan Nur, Mohsen Alzahrani, Ben Carpenter, William Tse, María Isabel, Hemalatha G. Rangarajan, Ibrahim Ahmed, Adeseye Michael Akinsete, Courtney D. Fitzhugh, Kathryn A. Culos, Leena Karnik, James A. Connelly, Carrie L. Kitko, Jennifer Andrews, Karina L Wilkerson, Robert A. Brodsky, Tatsuki Koyama, Michael R. DeBaun
Publié 2020Artigo -
7
Infection after CD19 chimeric antigen receptor T cell therapy for large B cell lymphoma: Real-world analysis from CIBMTR par Kitsada Wudhikarn, Megan M. Herr, Min Chen, Michael J. Martens, John H. Baird, Lohith Gowda, Hemalatha G. Rangarajan, Muhammad Bilal Abid, Mohamed A. Kharfan‐Dabaja, Kristen M. Williams, Siddhartha Ganguly, Jo‐Anne H. Young, Akshay Sharma, Giancarlo Fatobene, Tania Jain, Christopher G. Kanakry, Dipenkumar Modi, Natalie S. Grover, Baheyeldin Salem, Marjorie Vieira Batista, Paschalis Vergidis, Dwight E. Yin, Amer Beitinjaneh, Amar H. Kelkar, Taiga Nishihori, Jennifer Holter‐Chakrabarty, Usama Gergis, Melody Smith, Zeinab El Boghdadly, Christopher E. Dandoy, Hemant S. Murthy, Anna R. Huppler, Miguel‐Angel Perales, Roy F. Chemaly, Laurel A. Thur, Marcie L. Riches, Jeffery J. Auletta
Publié 2025Artigo -
8
Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases par Staci D. Arnold, Ruta Brazauskas, Naya He, Yimei Li, Richard Aplenc, Zhezhen Jin, Matt Hall, Yoshiko Atsuta, Jignesh Dalal, Theresa Hahn, Nandita Khera, Carmem Bonfim, Navneet S. Majhail, Miguel Ángel Díaz, César O. Freytes, William A. Wood, Bipin N. Savani, Rammurti T. Kamble, Susan K. Parsons, Ibrahim Ahmed, Keith M. Sullivan, Sara Beattie, Christopher E. Dandoy, Reinhold Munker, Susana R. Marino, Menachem Bitan, Hisham Abdel‐Azim, Mahmoud Aljurf, Richard F. Olsson, Sarita Joshi, Dave Buchbinder, Michael J. Eckrich, Shahrukh K. Hashmi, Hillard M. Lazarus, David I. Marks, Amir Steinberg, Ayman Saad, Usama Gergis, Lakshmanan Krishnamurti, Allistair Abraham, Hemalatha G. Rangarajan, Mark C. Walters, Joseph Lipscomb, Wael Saber, Prakash Satwani
Publié 2017Artigo -
9
Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis par Rima M. Saliba, Amin M. Alousi, Joseph Pidala, Mukta Arora, Stephen R. Spellman, Michael Hemmer, Tao Wang, Camille N. Abboud, Sairah Ahmed, Joseph H. Antin, Amer Beitinjaneh, David Buchbinder, Michael Byrne, Jean‐Yves Cahn, Hannah Choe, Rabi Hanna, Peiman Hematti, Rammurti T. Kamble, Carrie L. Kitko, Mary Laughlin, Lazaros J. Lekakis, Margaret L. MacMillan, Rodrigo Martino, Parinda A. Mehta, Taiga Nishihori, Sagar S. Patel, Miguel‐Angel Perales, Hemalatha G. Rangarajan, Olle Ringdén, Joseph Rosenthal, Bipin N. Savani, Kirk R. Schultz, Sachiko Seo, Takanori Teshima, Marjolein van der Poel, Leo F. Verdonck, Daniel Weisdorf, Baldeep Wirk, Jean A. Yared, Jeffrey Schriber, Richard E. Champlin, Stefan O. Ciurea
Publié 2022Artigo -
10
Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minorities par Nandita Khera, Sikander Ailawadhi, Ruta Brazauskas, Jinalben Patel, Benjamin Jacobs, Celalettin Üstün, Karen K. Ballen, Muhammad Bilal Abid, Miguel Ángel Díaz, A. Samer Al‐Homsi, Hasan Hashem, Sanghee Hong, Reinhold Munker, Raquel M. Schears, Hillard M. Lazarus, Stefan O. Ciurea, Sherif M. Badawy, Bipin N. Savani, Baldeep Wirk, Charles F. LeMaistre, Neel S. Bhatt, Amer Beitinjaneh, Mahmoud Aljurf, Akshay Sharma, Jan Černý, Jennifer M. Knight, Amar H. Kelkar, Jean A. Yared, Tamila L. Kindwall‐Keller, Lena E. Winestone, Amir Steinberg, Staci D. Arnold, Sachiko Seo, Jaime M. Preussler, Nasheed Hossain, Warren Fingrut, Vaibhav Agrawal, Shahrukh K. Hashmi, Leslie E. Lehmann, William A. Wood, Hemalatha G. Rangarajan, Wael Saber, Theresa Hahn
Publié 2024Artigo -
11
Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT par Rohtesh S. Mehta, Shernan G. Holtan, Tao Wang, Michael Hemmer, Stephen R. Spellman, Mukta Arora, Daniel R. Couriel, Amin M. Alousi, Joseph Pidala, Hisham Abdel‐Azim, Vaibhav Agrawal, Ibrahim Ahmed, A. Samer Al‐Homsi, Mahmoud Aljurf, Joseph H. Antin, Medhat Askar, Jeffery J. Auletta, Vijaya Raj Bhatt, Lynette Chee, Saurabh Chhabra, Andrew Daly, Zachariah DeFilipp, James Gajewski, Robert Peter Gale, Usama Gergis, Peiman Hematti, Gerhard Hildebrandt, William J. Hogan, Yoshihiro Inamoto, Rodrigo Martino, Navneet S. Majhail, David I. Marks, Taiga Nishihori, Richard F. Olsson, Attaphol Pawarode, Miguel Ángel Díaz, Tim Prestidge, Hemalatha G. Rangarajan, Olle Ringdén, Ayman Saad, Bipin N. Savani, Hélène Schoemans, Sachiko Seo, Kirk R. Schultz, Melhem Solh, Thomas R. Spitzer, Jan Storek, Takanori Teshima, Leo F. Verdonck, Baldeep Wirk, Jean A. Yared, Jean‐Yves Cahn, Daniel J. Weisdorf
Publié 2020Artigo
Outils de recherche:
Sujets similaires
Medicine
Internal medicine
Transplantation
Immunology
Biology
Chemotherapy
Cyclophosphamide
Stem cell
Clinical trial
Genetics
Graft-versus-host disease
Oncology
Gastroenterology
Haematopoiesis
Hematopoietic stem cell transplantation
Cancer
Cancer research
Cell therapy
Confidence interval
Fludarabine
Hazard ratio
Hematopoietic cell
Immune system
Surgery
ThioTEPA
Antigen
Biotechnology
Blinatumomab
Bone marrow
Bone marrow transplant